Refractory neuroblastoma, victory over pain (clinical case)

Authors

  • O O Kalinchuk Vinnytsia regional pediatric clinical hospital
  • T G Korol Vinnytsia National Pirogov Memorial Medical University
  • S S Blazhko Vinnytsia regional pediatric clinical hospital
  • N U Kosechenko Vinnytsia regional pediatric clinical hospital

DOI:

https://doi.org/10.31636/pmjua.v3i4.4

Keywords:

neuroblastoma, children, pain syndrome, palliative treatment

Abstract

Neuroblastoma is a malignant tumor that develops from the stem cells of the sympathetic ganglia and the adrenal medulla and belongs to the group of neuroendocrine tumors. It is most often localized in the adrenal glands and the retroperitoneal space, less – in sympathetic ganglia of the neck and thoracic cavity. Pain syn-drome is one of the leading manifestations in patients with disease progression. Unlike other patients, a pain syndrome in oncological patients is not a temporary or periodic sensation, it has no physio-logical expediency, it does not have a protective mechanism, but, on the contrary, pain in this group of patients leads to inadaptation, distorted perception of pain and small impulses, most importantly, accompanied by various disorders of the functions of the central nervous system in the patient’s body.

Downloads

Download data is not yet available.

References

Kirillova OA, Volkova LD, Mihajlova EV. Klinicheskie osobennosti i luchevaya diagnostika intraparavertebralnoj nejroblastomy u detej (Clinical features and radiological diagnosis of intrapravertebral neuroblastoma in children). Onkopediatriya. 2015;2(2):121–30. (In Russian)

Onishko VM, Dankevich OS, Krasulya OI, Strokan AM. Aktualni problemi klinichnoyi ta profilaktichnoyi medicini (The state camp of chronical pain syndrome in oncologic diseases by the method of neurolysis chemotherapy). Aktualni problemi klinichnoyi ta profilaktichnoyi medicini. 2013;2(1):76–82. (In Ukrainian)

Stroganova AM, Karseladze AI. Nejroblastoma: morfologicheskaya struktura, molekulyarno-geneticheskie osobennosti iprognosticheskie faktory (Neuroblastoma: morphological structure, molecular genetic features and prognostic factors). Uspehi molekulyarnoj onkologii. 2016;1(3):32–43. (In Russian)

Fesenko MY, Pohilko VI, Sherban OA. Vipadok nejroblastomi u novonarodzhenoyi ditini (A case of neuroblastoma in a newborn child). Visnik problem biologiyi imedicini. 2017;1(135):211–4. (In Ukrainian)

Shamanskaya TV, Burgol MM, Kachanov DY. Associaciya vrozhdennyh porokov serdca i nejroblastomy u detej (Association of congenital heart defects and neuroblastoma of girls). Voprosy gematologii / onkologii i immunopatologii v pediatrii. 2018;17(3):28–35. (In Russian)

Brodeur GM, Bagatell R. Mechanisms of neuroblastoma regression. Nature Reviews Clinical Oncology [Internet]. Springer Science and Business Media LLC; 2014 Oct 21;11(12):704–13. Available from: https://doi.org/10.1038/nrclinonc.2014.168

Carlson C. Effectiveness of the World Health Organization Cancer Pain Relief Guidelines: an integrative review. Journal of Pain Research [Internet]. Dove Medical Press Ltd.; 2016 Jul;Volume 9:515–34. Available from: https://doi.org/10.2147/jpr.s97759

Connor SR, Bermedo MC. Global Atlas of Palliative Care at the End of Life. Geneva, Switzerland– London, UK: World Health Organization, the Worldwide Palliative Care Alliance.2014.

Iehara T, Hiyama E, Tajiri T, Yoneda A, Hamazaki M, Fukuzawa M, et al. Is the prognosis of stage 4s neuroblastoma in patients 12months of age and older really excellent? European Journal of Cancer [Internet]. Elsevier BV; 2012 Jul;48(11):1707–12. Available from: https://doi.org/10.1016/j.ejca.2012.01.010

Gustafson WC, Weiss WA. Myc proteins as therapeutic targets. Oncogene [Internet]. Springer Nature; 2010 Jan 25;29(9):1249–59. Available from: https://doi.org/10.1038/onc.2009.512

Harstall C, Ospina M. How Prevalent Is Chronic Pain? Pain: Clinical Updates.2003; Vol.11, Issue 2:1–4.

Malis J. Clinical Presentation of Neuroblastoma. Neuroblastoma [Internet]. InTech; 2013 May 29; Available from: https://doi.org/10.5772/55921

Minozzi S, Amato L, Davoli M. Development of dependence following treatment with opioid analgesics for pain relief: a systematic review. Addiction [Internet]. Wiley; 2012 Oct 18;108(4):688–98. Available from: https://doi.org/10.1111/j.1360-0443.2012.04005.x

International Narcotics Control Board. Narcotic Drugs 2012 [Internet]. UN; 2013 Apr 15;441–7. Available from: https://doi.org/10.18356/70e189f4-en-fr-es

Krakauer EL, Wenk R, Buitrago R, Jenkins P, Scholten W. Opioid Inaccessibility and Its Human Consequences: Reports From the Field. Journal of Pain & Palliative Care Pharmacotherapy [Internet]. Informa UK Limited; 2010 Aug;24(3):239–43. Available from: https://doi.org/10.3109/15360288.2010.501852

Rocque GB, Cleary JF. Palliative care reduces morbidity and mortality in cancer. Nature Reviews Clinical Oncology [Internet]. Springer Science and Business Media LLC; 2012 Dec 18;10(2):80–9. Available from: https://doi.org/10.1038/nrclinonc.2012.211

Рефрактерна нейробластома, перемога над болем (клінічний випадок)

Published

2019-02-21

How to Cite

1.
Kalinchuk OO, Korol TG, Blazhko SS, Kosechenko NU. Refractory neuroblastoma, victory over pain (clinical case). PMJUA [Internet]. 2019 Feb. 21 [cited 2024 Mar. 28];3(4):64-58. Available from: https://painmedicine.org.ua/index.php/pnmdcn/article/view/167

Issue

Section

Clinical thinking

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.